Net clinical benefit of anticoagulation therapy in the elderly patients with atrial fibrillation

Lorenzo Palleschi1, Eleonora Nunziata

  • 1Hospital S. Giovanni-Addolorata, Unit of Geriatrics. ele.nunziata@gmail.com.

Insights

Older adults with atrial fibrillation (AF) face high stroke risk. Oral anticoagulation (OAC) effectively prevents clots, with newer non-vitamin K oral anticoagulants (NOACs) offering expanded treatment options for this population.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Atrial fibrillation (AF) significantly increases stroke risk, particularly in older adults.
  • Oral anticoagulation (OAC) is the cornerstone of thromboembolic event prevention in AF patients.
  • Traditional OAC agents include aspirin and vitamin-K antagonists (VKAs).

Purpose of the Study:

  • To review practical considerations for selecting and using OAC in elderly patients with AF.
  • To aid clinicians in making informed OAC treatment decisions for older adults.
  • To discuss the role of novel oral anticoagulants in managing AF-related stroke risk.

Main Methods:

  • Literature review of OAC agents for atrial fibrillation.
  • Analysis of clinical guidelines and evidence for OAC use in the elderly.
  • Discussion of practical aspects of OAC selection and administration.

Main Results:

  • Older age is a major risk factor for stroke in AF.
  • Non-vitamin K oral anticoagulants (NOACs) represent a significant advancement in OAC therapy.
  • Effective OAC management is crucial for reducing thromboembolic disease in elderly AF patients.

Conclusions:

  • OAC therapy is essential for stroke prevention in elderly patients with AF.
  • NOACs provide valuable alternatives to VKAs, expanding therapeutic options.
  • Careful consideration of patient-specific factors is necessary for optimal OAC selection in older adults.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.0K
Amyloid Fibrils03:03

Amyloid Fibrils

6.5K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.4K
Benefits of Self-Esteem01:25

Benefits of Self-Esteem

Self-esteem—an individual's overall evaluation of their worth—plays a complex role in psychological functioning and well-being. It is often associated with many positive traits, such as confidence, optimism, and perseverance. Individuals with high self-esteem typically experience better sleep, manage peer pressure more effectively, and report greater life satisfaction. Conversely, low self-esteem has been consistently linked with increased risks of depression, anxiety, and poor...
212
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.9K